New York State Common Retirement Fund’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
NNPTE
PAM
YIH
BCM
WG
New York State Common Retirement Fund's JANX Position: Q2 2026 in Review
New York State Common Retirement Fund held its Janux Therapeutics (JANX) position steady in Q2 2026 at 11,746 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.
New York State Common Retirement Fund first reported a position in JANX in Q3 2021 and has held it in 20 quarters since. The position peaked at $855K in Q4 2024. 67 funds tracked by Wall St. Rank hold JANX as of Q2 2026.
- New York State Common Retirement Fund held 11,746 shares of Janux Therapeutics worth $180K as of Q2 2026.
- New York State Common Retirement Fund left its Janux Therapeutics share count unchanged in Q2 2026.
- Janux Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2416 holding.
- New York State Common Retirement Fund first reported a position in Janux Therapeutics in Q3 2021 and has held it in 20 quarters since.
- New York State Common Retirement Fund's Janux Therapeutics position peaked at $855K in Q4 2024.
- 67 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.